CSIMarket


Candel Therapeutics Inc   (CADL)
Other Ticker:  
 

Candel Therapeutics Inc 's Quick Ratio

CADL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




CADL Quick Ratio (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter



Y / Y Current Liabilities Change - - - - -
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ 20.1 5.41 - - -
Overall Ranking # 294 # 1005 # 1 # #
Seq. Current Liabilities Change -2.16 % - - - -
Seq. Cash & cash equivalent Change 263.48 % - - - -



Quick Ratio third quarter 2021 Comment
Candel Therapeutics Inc 's Cash & cash equivalent grew by 263.48 % in III. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Candel Therapeutics Inc 's Quick Ratio to 20.1, Quick Ratio remained below Candel Therapeutics Inc average.

Within Biotechnology & Pharmaceuticals industry 27 other companies have achieved higher Quick Ratio than Candel Therapeutics Inc in third quarter 2021. While Quick Ratio total ranking has improved so far to 294, from total ranking in previous quarter at 1005.

Explain Quick Ratio?
What are CADL Segments?
See Quick Ratio CADL on the trailing twelve month basis
Quick Ratio third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 28
Healthcare Sector # 113
Overall Market # 294


Quick Ratio Statistics
High Average Low
20.1 12.76 5.41
(Sep 30 2021)   (Jun 30 2021)




Financial Statements
Candel Therapeutics Inc 's Current Liabilities $ 4 Millions Visit CADL's Balance sheet
Candel Therapeutics Inc 's Cash & cash equivalent $ 88 Millions Visit CADL's Balance sheet
Source of CADL's Sales Visit CADL's Sales by Geography




Companies with similar Quick Ratio in the quarter endingSep 30 2021, within Biotechnology & Pharmaceuticals Industry Quick RatioSep 30 2021 MRQ Cash & cash equivalentSep 30 2021 MRQ Current Liabilities
Talaris Therapeutics Inc   51.13 $ 254.734  Millions$ 4.982  Millions
Infinity Pharmaceuticals Inc   49.91 $ 90.088  Millions$ 1.805  Millions
Passage Bio inc   39.47 $ 354.401  Millions$ 8.978  Millions
Icosavax Inc   35.57 $ 291.271  Millions$ 8.188  Millions
Nanovibronix Inc  33.59 $ 8.599  Millions$ 0.256  Millions
Protara Therapeutics Inc   32.92 $ 93.758  Millions$ 2.848  Millions
Rubius Therapeutics inc   31.09 $ 264.017  Millions$ 8.492  Millions
Cardiff Oncology inc   30.14 $ 134.047  Millions$ 4.448  Millions
Monte Rosa Therapeutics Inc   28.80 $ 367.034  Millions$ 12.743  Millions
Vor Biopharma Inc   28.03 $ 225.968  Millions$ 8.063  Millions
In8bio Inc   26.55 $ 40.675  Millions$ 1.532  Millions
Replimune Group Inc   26.19 $ 435.771  Millions$ 16.636  Millions
Crispr Therapeutics Ag  25.75 $ 2,477.360  Millions$ 96.206  Millions
Lixte Biotechnology Holdings Inc   25.69 $ 5.961  Millions$ 0.232  Millions
Athira Pharma Inc   25.12 $ 235.775  Millions$ 9.386  Millions
Salarius Pharmaceuticals inc   24.75 $ 31.904  Millions$ 1.289  Millions
Renovacor Inc   23.15 $ 85.321  Millions$ 3.686  Millions
Assembly Biosciences inc   22.38 $ 180.902  Millions$ 8.085  Millions
Kymera Therapeutics Inc   21.78 $ 536.386  Millions$ 24.627  Millions
Protokinetix Incorporated  20.76 $ 0.145  Millions$ 0.007  Millions
Tenaya Therapeutics Inc   20.48 $ 280.465  Millions$ 13.692  Millions
Organovo Holdings Inc   20.17 $ 33.791  Millions$ 1.675  Millions
Candel Therapeutics Inc   20.10 $ 88.385  Millions$ 4.397  Millions
Atyr Pharma Inc   19.99 $ 116.354  Millions$ 5.820  Millions
Immunovant Inc   19.69 $ 558.952  Millions$ 28.383  Millions
Ginkgo Bioworks Holdings Inc   19.26 $ 1,739.056  Millions$ 90.305  Millions
Denali Therapeutics Inc   19.15 $ 1,039.175  Millions$ 54.251  Millions
Bionano Genomics Inc   18.86 $ 326.069  Millions$ 17.291  Millions
Solid Biosciences Inc   18.80 $ 229.760  Millions$ 12.224  Millions
Tarsus Pharmaceuticals Inc   17.73 $ 183.801  Millions$ 10.365  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SDPI's Profile

Stock Price

SDPI's Financials

Business Description

Fundamentals

Charts & Quotes

SDPI's News

Suppliers

SDPI's Competitors

Customers & Markets

Economic Indicators

SDPI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071